Full Text
HPR177 Modeled Impact of Risk-Sharing Agreements on Costs for Hemophilia B Gene Therapy in Germany

Abstract

Authors

L Falk J Schreyögg

Back to Volume 27, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×